JPWO2020247603A5 - - Google Patents

Download PDF

Info

Publication number
JPWO2020247603A5
JPWO2020247603A5 JP2021572445A JP2021572445A JPWO2020247603A5 JP WO2020247603 A5 JPWO2020247603 A5 JP WO2020247603A5 JP 2021572445 A JP2021572445 A JP 2021572445A JP 2021572445 A JP2021572445 A JP 2021572445A JP WO2020247603 A5 JPWO2020247603 A5 JP WO2020247603A5
Authority
JP
Japan
Prior art keywords
solid oral
dosage form
oral dosage
weight
amisulpride
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2021572445A
Other languages
English (en)
Japanese (ja)
Other versions
JP2022535894A (ja
Publication date
Application filed filed Critical
Priority claimed from PCT/US2020/036084 external-priority patent/WO2020247603A1/en
Publication of JP2022535894A publication Critical patent/JP2022535894A/ja
Publication of JPWO2020247603A5 publication Critical patent/JPWO2020247603A5/ja
Pending legal-status Critical Current

Links

JP2021572445A 2019-06-04 2020-06-04 放出調節製剤およびその使用 Pending JP2022535894A (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201962856863P 2019-06-04 2019-06-04
US62/856,863 2019-06-04
US202063011584P 2020-04-17 2020-04-17
US63/011,584 2020-04-17
PCT/US2020/036084 WO2020247603A1 (en) 2019-06-04 2020-06-04 Modified release formulations and uses thereof

Publications (2)

Publication Number Publication Date
JP2022535894A JP2022535894A (ja) 2022-08-10
JPWO2020247603A5 true JPWO2020247603A5 (es) 2023-06-13

Family

ID=73652146

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2021572445A Pending JP2022535894A (ja) 2019-06-04 2020-06-04 放出調節製剤およびその使用

Country Status (4)

Country Link
US (1) US20220323409A1 (es)
EP (1) EP3980008A4 (es)
JP (1) JP2022535894A (es)
WO (1) WO2020247603A1 (es)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2019113084A1 (en) 2017-12-05 2019-06-13 Sunovion Pharmaceuticals Inc. Crystal forms and production methods thereof
KR20220018004A (ko) 2019-06-04 2022-02-14 선오비온 파마슈티컬스 인코포레이티드 조절 방출 제형 및 이의 용도

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2010023690A2 (en) * 2008-08-28 2010-03-04 Torrent Pharmaceuticals Ltd. Prolonged release formulation of amisulpride
GB201004020D0 (en) * 2010-03-11 2010-04-21 Acacia Pharma Ltd New therapeutic use
US10441544B2 (en) * 2017-10-10 2019-10-15 Douglas Pharmaceuticals, Ltd. Extended release pharmaceutical formulation
SG11202005016SA (en) * 2017-12-05 2020-06-29 Sunovion Pharmaceuticals Inc Nonracemic mixtures and uses thereof
KR20220018004A (ko) * 2019-06-04 2022-02-14 선오비온 파마슈티컬스 인코포레이티드 조절 방출 제형 및 이의 용도

Similar Documents

Publication Publication Date Title
US8796337B2 (en) Composition and method for treating neurological disease
US7374781B2 (en) Sustained release formulations containing acetaminophen and tramadol
TWI241911B (en) Sustained release ranolazine formulations
US20070298098A1 (en) Controlled Release Compositions Comprising Levetiracetam
WO2009034541A9 (en) Controlled release pharmaceutical dosage forms of trimetazidine
WO2021129735A1 (zh) 一种固体制剂及其制备方法和用途
AU2014299447B2 (en) Pharmaceutical capsule composite formulation comprising tadalafil and tamsulosin
KR101156054B1 (ko) 안정한 에페리손 함유 서방성 의약조성물
RU2006122517A (ru) Фармацевтический состав для прямого прессования, предназначенный для перорального введения cci-779
AU2012349771A1 (en) Methods for treating cardiovascular disorder
RU2008137229A (ru) Ниацинсодержащая фармацевтическая композиция (варианты) и таблеточный препарат (варианты), способ снижения гиперемии и способ приготовления ниацинсодержащей таблетки
KR20170008923A (ko) 세레콕시브 및 트라마돌을 함유하는 약제학적 조성물
WO2023241688A1 (zh) 一种用于治疗抗凝血的药物组合物及应用
KR20120033557A (ko) 레보드로프로피진을 포함하는 속효성과 지속성을 동시에 갖는 약제학적 조성물
KR20100008356A (ko) 칼슘채널길항제를 포함하는 약제학적 제제
WO2006088864A1 (en) Controlled release compositions comprising levetiracetam
AU2011288256A1 (en) Oral controlled release pharmaceutical compositions of Blonanserin
WO2007010501A2 (en) A pharmaceutical composition comprising a combination of beta blocker and an ace inhibitor
JPWO2020247603A5 (es)
JP2016539171A (ja) アセブロフィリン及び疎水性徐放性基剤を含む徐放性薬学組成物
JPWO2020247627A5 (es)
KR20140118412A (ko) 활성 성분으로 에페리손을 함유하는 서방성 제제 조성물
JP2016539109A (ja) イソニアジドの顆粒およびリファペンチンの顆粒を含むコーティング錠の形態の抗結核性の安定な医薬組成物ならびにその製造方法
EP3727365A2 (en) Modified release formulations of flurbiprofen
KR102330953B1 (ko) 소듐-1-[6-(모르폴린-4-일)피리미딘-4-일]-4-(1h-1,2,3-트리아졸-1-일)-1h-피라졸-5-올레이트를 함유하는 제약 투여 형태